Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial

Kari L. Kendra, Shay L. Bellasea, Zeynep Eroglu, Siwen Hu-Lieskovan, Katie M. Campbell, William E. Carson, David A. Wada, Jose A. Plaza, Jeffrey A. Sosman, Gino K. In, Alexandra Ikeguchi, John Hyngstrom, Andrew S. Brohl, Nikhil I. Khushalani, Joseph Markowitz, George Negrea, Samer Kasbari, Gary C. Doolittle, Umang Swami, Toni Roberts, Boban N. Mathew, Egmidio Medina, Ignacio Baselga-Carretero, Cynthia R. Gonzalez, Ivan Perez Garcilazo, Agustin Vega-Crespo, Jia Ming Chen, Nataly Naser Al-Deen, Sapna P. Patel, Elad Sharon, James Moon, Michael C. Wu, Antoni Ribas

Open source

DOI: 10.1038/s41591-025-03875-5
Published: 2025-08-14
Container: Nature Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-025-03875-5,
  title = {Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial},
  author = {Kari L. Kendra and Shay L. Bellasea and Zeynep Eroglu and Siwen Hu-Lieskovan and Katie M. Campbell and William E. Carson and David A. Wada and Jose A. Plaza and Jeffrey A. Sosman and Gino K. In and Alexandra Ikeguchi and John Hyngstrom and Andrew S. Brohl and Nikhil I. Khushalani and Joseph Markowitz and George Negrea and Samer Kasbari and Gary C. Doolittle and Umang Swami and Toni Roberts and Boban N. Mathew and Egmidio Medina and Ignacio Baselga-Carretero and Cynthia R. Gonzalez and Ivan Perez Garcilazo and Agustin Vega-Crespo and Jia Ming Chen and Nataly Naser Al-Deen and Sapna P. Patel and Elad Sharon and James Moon and Michael C. Wu and Antoni Ribas},
  year = {2025},
  journal = {Nature Medicine},
  doi = {10.1038/s41591-025-03875-5},
  url = {https://doi.org/10.1038/s41591-025-03875-5}
}

RIS

TY  - JOUR
TI  - Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial
AU  - Kari L. Kendra
AU  - Shay L. Bellasea
AU  - Zeynep Eroglu
AU  - Siwen Hu-Lieskovan
AU  - Katie M. Campbell
AU  - William E. Carson
AU  - David A. Wada
AU  - Jose A. Plaza
AU  - Jeffrey A. Sosman
AU  - Gino K. In
AU  - Alexandra Ikeguchi
AU  - John Hyngstrom
AU  - Andrew S. Brohl
AU  - Nikhil I. Khushalani
AU  - Joseph Markowitz
AU  - George Negrea
AU  - Samer Kasbari
AU  - Gary C. Doolittle
AU  - Umang Swami
AU  - Toni Roberts
AU  - Boban N. Mathew
AU  - Egmidio Medina
AU  - Ignacio Baselga-Carretero
AU  - Cynthia R. Gonzalez
AU  - Ivan Perez Garcilazo
AU  - Agustin Vega-Crespo
AU  - Jia Ming Chen
AU  - Nataly Naser Al-Deen
AU  - Sapna P. Patel
AU  - Elad Sharon
AU  - James Moon
AU  - Michael C. Wu
AU  - Antoni Ribas
PY  - 2025
JO  - Nature Medicine
DO  - 10.1038/s41591-025-03875-5
UR  - https://doi.org/10.1038/s41591-025-03875-5
ER  -

APA

Kendra, K. L., Bellasea, S. L., Eroglu, Z., Hu-Lieskovan, S., Campbell, K. M., Carson, W. E., Wada, D. A., Plaza, J. A., Sosman, J. A., In, G. K., Ikeguchi, A., Hyngstrom, J., Brohl, A. S., Khushalani, N. I., Markowitz, J., Negrea, G., Kasbari, S., Doolittle, G. C., Swami, U., Roberts, T., Mathew, B. N., Medina, E., Baselga-Carretero, I., Gonzalez, C. R., Garcilazo, I. P., Vega-Crespo, A., Chen, J. M., Al-Deen, N. N., Patel, S. P., Sharon, E., Moon, J., Wu, M. C., & Ribas, A. (2025). Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial. Nature Medicine. https://doi.org/10.1038/s41591-025-03875-5

Source records

crossref · retrieved 2026-09-27T12:08:14.856Z